RecruitingNot ApplicableNCT06974279

Post-Stroke Aphasia TMS

Precision Neuromodulation in Post-Stroke Aphasia Using TMS


Sponsor

Medical College of Wisconsin

Enrollment

50 participants

Start Date

Sep 1, 2025

Study Type

INTERVENTIONAL

Conditions

Summary

The investigator proposes to examine the effects of excitatory transcranial magnetic stimulation (TMS) combined with semantic feature analysis (SFA) language therapy to improve word-finding abilities in stroke survivors with aphasia (SWA).


Eligibility

Min Age: 18 Years

Inclusion Criteria4

  • Diagnosed with left hemisphere stroke
  • Consent date \>= 1 month after stroke onset
  • Fluent in English
  • years of age or older

Exclusion Criteria9

  • Severe cognitive, auditory or visual impairments that would preclude cognitive and language testing
  • Presence of major untreated or unstable psychiatric disease (e.g. schizophrenia, bipolar disease)
  • A chronic medical condition that is not treated or is unstable
  • The presence of cardiac stimulators or pacemakers or intracardiac lines, neurostimulators, medication infusion device, any other implants near the scalp (e.g., cochlear implants) or in the eye, metal in the body (e.g., splinters, fragments, clips)
  • Pregnancy
  • History of skull fractures, or skin diseases
  • History of ongoing or unmanaged seizures
  • Presence of factors that potentially decrease seizure thresholds: on pro-convulsant medications, untreated sleep deprivation or insomnia, ongoing alcoholism or illegal drug abuse (e.g., cocaine or MDMA users)
  • History of dyslexia or other developmental learning disabilities

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICEPrecision TMS with SFA

Excitatory TMS delivered using a precision site finding approach and intermittent theta burst stimulation protocol

DEVICEControl TMS with SFA

Excitatory TMS using intermittent theta burst stimulation delivered to a control vertex site.


Locations(1)

Medical College of Wisconsin

Milwaukee, Wisconsin, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06974279


Related Trials